Capmatinib 2HCl

• Target:

  C-Met/HGFR|||Apoptosis

• Related Pathways:

  Apoptosis|||Tyrosine Kinase/Adaptors

• Purity:

  >99.99%

• Bioactivity:

  Capmatinib 2HCl (INC-280 2HCl) is a novel, ATP-competitive inhibitor of c-MET kinase with an IC50 with 0.13 nM.Capmatinib 2HCl exhibits picomolar enzymatic potency and is highly specific for c-MET with more than 10, 000-fold selectivity over a large panel of human kinases. This inhibitor potently blocks c-MET phosphorylation and activation of its key downstream effectors in c-MET-dependent tumor cell lines. As a result, Capmatinib 2HCl potently inhibits c-MET-dependent tumor cell proliferation and migration and effectively induces apoptosis in vitro.

• Smiles:

  Cl.Cl.CNC(=O)c1ccc(cc1F)-c1cnc2ncc(Cc3ccc4ncccc4c3)n2n1

• Molecular Formula:

  C23H19Cl2FN6O

• Molecular Weight:

  485.34

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C

• CAS Number:

  1197376-85-4